Evaluation of albumin consumption and adherence to FDA approval guideline in patients admitted to the intensive care unit ward of Vali-e-Asr and Razi Hospitals of Birjand, 2022

Rajnbar, Mahdieh; Shakhs Emampour, Bibi Fatemeh; Sharifzadeh, Gholamreza; Ramezani, Melika; Avan, Razieh

doi:10.61186/JBUMS.32.1.59

Volume 32, Issue 1 (Spring 2025) J Birjand Univ Med Sci. 2025, 32(1): 59-68 | Back to browse issues page

‎ 10.61186/JBUMS.32.1.59

Research code: 456909

Ethics code: IR.BUMS.REC.1401.400

Mendeley

Zotero

RefWorks

Rajnbar M, Shakhs Emampour B F, Sharifzadeh G, Ramezani M, Avan R. Evaluation of albumin consumption and adherence to FDA approval guideline in patients admitted to the intensive care unit ward of Vali-e-Asr and Razi Hospitals of Birjand, 2022. J Birjand Univ Med Sci. 2025; 32 (1) :59-68
URL: http://journal.bums.ac.ir/article-1-3477-en.html

Evaluation of albumin consumption and adherence to FDA approval guideline in patients admitted to the intensive care unit ward of Vali-e-Asr and Razi Hospitals of Birjand, 2022

Mahdieh Rajnbar¹

, Bibi Fatemeh Shakhs Emampour²

, Gholamreza Sharifzadeh³

, Melika Ramezani¹

, Razieh Avan ^*⁴

1- Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
2- Department of Anesthesiology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
3- Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
4- Department of Clinical Pharmacy, School of Pharmacy, Pharmaceutical Sciences Research Center, Birjand University of Medical Sciences, Birjand, Iran , avanr91@gmail.com

Abstract: (224 Views)

Background and Aims: Albumin is a biological and expensive medicine obtained from blood in a limited way and through a difficult production process. With reference to some studies conducted in Iran regarding the incorrect use of this drug, the present study aimed to assess the albumin consumption and evaluate compliance with FDA approval guidelines in patients admitted to intensive care units (ICUs) of Vali Asr and Razi Birjand hospitals in 2022.
Materials and Methods: In this descriptive-analytical study, 140 hospitalized patients receiving albumin in the ICU ward of Birjand hospitals were included. The demographic information of the patients, conformity of administration and dosage with instructions, and the side effects of albumin were recorded from the patients' files in the relevant checklist.
Results: The mean age of the patients was 67.3±16.9 years. In terms of gender, 54.3% of the studied patients were male. The most common cause of albumin administration was hypovolemia. Moreover, 95.7% of the cases of albumin administration in patients and the prescribed dose in 69.3% of them were in accordance with FDA guidelines. There was a significant difference in the indication of albumin administration according to the specialty of the attending physician (P=0.01).

Conclusion: As evidenced by the results of the present study, 95.7% of the prescription indications and 69.3% of the dosage of albumin were in accordance with the FDA guidelines. Therefore, preparing a protocol for rational albumin use and holding training workshops for relevant specialists can be useful for improving the correct prescription of this essential and expensive medication.

Keywords: Albumin, Drug utilization evaluation, FDA guidelines, Intensive care unit

Full-Text [PDF 484 kb] (67 Downloads)

Type of Study: Original Article | Subject: Pharmacy
Received: 2024/11/1 | Accepted: 2025/03/15 | ePublished ahead of print: 2025/05/31 | ePublished: 2025/04/4

References

1. Zhou T, Lu S, Liu X, Zhang Y, Xu F. Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China. Patient Prefer Adherence. 2013; 7: 1207-12. DOI: 10.2147/PPA.S53484 [DOI:10.2147/PPA.S53484] [PMID] []

2. Asrorov AM, Mukhamedov N, Kayumov M, Yashinov AS, Wali A, Yili A, et al. Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy. Med. Drug Discov. 2024; 100186. DOI: 10.1016/j.medidd.2024.100186 [DOI:10.1016/j.medidd.2024.100186]

3. Belinskaia D, Voronina P, Goncharov N. Integrative role of albumin: evolutionary, biochemical and pathophysiological aspects. J Evol Biochem Physiol. 2021; 57(6): 1419-48. DOI: 10.1134/S002209302106020X [DOI:10.1134/S002209302106020X] [PMID] []

4. Jahangard-Rafsanjania Z, Javadib MR, Torkamandia H, Alahyaria S, Talasaza AH, Gholamib K. The Evaluation of Albumin Utilization in a Teaching University Hospital in Iran. Iran J Pharm Res. 2011; 10(2): 385-90. PMID: 24250369

5. Callum J, Skubas NJ, Bathla A, Keshavarz H, Clark EG, Rochwerg B, et al. Use of intravenous albumin: a guideline from the international collaboration for transfusion medicine guidelines. Chest. 2024; 166(2): 321-38. DOI: 10.1016/j.chest.2024.02.049 [DOI:10.1016/j.chest.2024.02.049] [PMID] []

6. Hosseini KM, Heidari M, Yari F. The preparation of albumin as a biological drug from human plasma by fiber filtration. Tehran Univ Med J. 2011; 69(5): 283-8.URL: http://tumj.tums.ac.ir/article-1-231-en.html

7. Zolfagharian F, Ghazanfari S, Elyasi S, Iraji P, Saberi MR, Vahdati-Mashhadian N, et al. Drug utilization evaluation of albumin in a teaching hospital of Mashhad, Iran: an interventional pre-post design study. Int J Clin Pharm. 2017; 39(4): 704-11. DOI: 10.1007/s11096-017-0458-y [DOI:10.1007/s11096-017-0458-y] [PMID]

8. Noori M, Salamzadeh J, Hajiesmaeili M, Rezaeimirghaed O, Moradi O, Saffaei A, et al. Evaluation of the appropriateness of albumin usage in a Teaching Hospital in Iran: The impact of clinical pharmacist intervention. Shiraz E-Medical Journal. 2021; 22(4): e102178. https://doi.org/10.5812/semj.102178 [DOI:10.5812/semj.102178.]

9. Huang X, Jiang X, Xiong F, Fu X, Hong L, Xu X, et al. Rational use of human albumin: plan-do-check-act cycle in clinical practice. BMJ Supportive & Palliative Care. 2025: spcare-2024-005268. DOI:10.1136/spcare-2024-005268 [DOI:10.1136/spcare-2024-005268] [PMID]

10. Ala S, Salehifar E, Chalaki V. Evaluation of albumin use in a teaching hospital. Mazandaran Univ Med Sci. 2015; 25(129): 137-41. URL: http://jmums.mazums.ac.ir/article-1-6266-en.html [Persian]

11. Remohí MJT, Arcos AS, Ramos BS, Paloma JB, Aznar MDG. Costs related to inappropriate use of albumin in Spain. Ann Pharmacother. 2000; 34(10): 1198-205. DOI: 10.1345/aph.19385 [DOI:10.1345/aph.19385] [PMID]

12. Dastan F, Jamaati H, Emami H, Haghgoo R, Eskandari R, Hashemifard SS, et al. Reducing Inappropriate. Utilization of Albumin: The Value of Pharmacist-led Intervention Model. Iran J Pharm Res. 2018; 17(3): 1125-9. PMCID: PMC6094441

13. Talasaz AH, Jahangard-Rafsanjani Z, Ziaie S, Fahimi F. Evaluation of the pattern of human albumin utilization at a university affiliated hospital. Arch Iran Med. 2012; 15(2): 85-7. PMID: 22292577

14. Buckley MS, Agarwal SK, Lansburg JM, Kopp BJ, Erstad BL. Clinical Pharmacist-Led Impact on Inappropriate Albumin Utilization and Associated Costs in General Ward Patients. Annals of Pharmacotherapy. 2020; 55(1): 44-51. DOI: 10.1177/1060028020935575 [DOI:10.1177/1060028020935575] [PMID]

15. Shafiee E, Rezaee H, Entezari T, Hamishehkar H. The Evaluation of Albumin Use in an Iranian University Hospital. Pharm Sci. 2016; 22(3): 186-9. DOI: 10.15171/PS.2016.29 [DOI:10.15171/PS.2016.29]

16. Rezapour A, Javan-Noughabi J, Salehiniya H, Kassani A, Sadeghi A. Albumin Usage in Iran. Arch Iran Med. 2019; 22(12): 722-7. PMID: 31823624

17. Farsad BF, Hadavand N, Masumi S, Salehi H. Albumin utilization review to evaluate the efficacy and cost, perform as a qualitative study in special wards in Shaheed Rajaei cardiovascular, medical &research center. Biosciences Biotechnology Research Asia. 2016; 13(3): 1469-77. DOI: 10.13005/bbra/2290 [DOI:10.13005/bbra/2290]

18. Coyle T, John SM. Evaluation of albumin use in a community hospital setting: A retrospective study looking at appropriate use and prescribing patterns. PloS one. 2021; 16(10): e0257858. DOI: 10.1371/journal.pone.0257858 [DOI:10.1371/journal.pone.0257858] [PMID] []

19. Tanzi M, Gardner M, Megellas M, Lucio S, Restino M. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm. 2003; 60(13): 1330-5. DOI: 10.1093/ajhp/60.13.1330 [DOI:10.1093/ajhp/60.13.1330] [PMID]

20. Jug R, Callum J, Ruijs T, Liu Y, Barty R, Thompson T. Intravenous albumin utilization audit at a large community hospital. Transfusion. 2024; 64(1): 39-46. DOI: 10.1111/trf.17610 [DOI:10.1111/trf.17610] [PMID]

21. Kazemi Y, Hadavand N, Hayatshahi A, Torkamandi H, Gholami K, Hadjibabaie M, et al. Albumin utilization in a teaching hospital in Tehran: time to revise the prescribing strategies. J Pharm Care. 2015

22. 1(4): 2013: 127-32. URL: https://jpc.tums.ac.ir/index.php/jpc/article/view/29

23. Valapour H, Jarrahzadeh M, Sohrevardi S. Pattern of albumin consumption in patients hospitalized in intensive care unit of two teaching hospitals in Iran. Adv Pharmacol Ther J. 2021; 1(1): 23-30. DOI: [DOI:10.18502/aptj.v1i1.7957]

24. Buckley MS, Knutson KD, Agarwal SK, Lansburg JM, Wicks LM, Saggar RC, et al. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill. Ann Pharmacother. 2020; 54(2): 105-12. DOI: 10.1177/1060028019877471 [DOI:10.1177/1060028019877471] [PMID]

25. Mousavi M, Dashti-Khavidaki S, Khalili H, Farshchi A, Gatmiri M. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency. Int J Pharm Pract. 2013; 21(4): 263-9. DOI: 10.1111/ijpp.12005 [DOI:10.1111/ijpp.12005] [PMID]

26. Aramwit P, Kasettratat N. Evaluation of serum albumin utilization in inpatient at a private hospital in Bangkok. Yakugaku Zasshi. 2004; 124(9): 631-4. DOI: 10.1248/yakushi.124.631 [DOI:10.1248/yakushi.124.631] [PMID]

27. Castillo AM, Natkowski J, Rubal-Peace G. Assessing adherence to current national guidelines for appropriate albumin use at an academic medical center. Pharm Pract. 2018; 16(2): 1190. DOI: 10.18549/PharmPract.2018.02.1190 [DOI:10.18549/PharmPract.2018.02.1190] [PMID] []

28. Shasthry SM, Kumar M, Khumuckham JS, Sarin SK. Changes in cardiac output and incidence of volume overload in cirrhotics receiving 20% albumin infusion. Liver Int. 2017; 37(8): 1167-76. DOI: 10.1111/liv.13375 [DOI:10.1111/liv.13375] [PMID]

29. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin--serious adverse events reported worldwide in 1998-2000. Br J Anaesth. 2003; 91(5): 625-30. DOI: 10.1093/bja/aeg233 [DOI:10.1093/bja/aeg233] [PMID]